Orakl
Orakl is a biotechnology company that concerns with cancer treatment and drug development.
Orakl is a business in biotechnology, medical, oncology, service industry based in European Union (EU), Europe, Middle East, and Africa (EMEA), founded in 2023.
Within the biotechnology, medical, oncology, service industry space, the company focuses on its core offering rather than a broad product line.
Its base of operations is European Union (EU), Europe, Middle East, and Africa (EMEA).
Its current recorded stage is Non_Equity_Assistance.
The company reports a headcount in the c_00001_00010 range.
| Sector | Biotechnology, Medical, Oncology, Service Industry |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Country | France |
| Founded | 2023 |
| Employees | c_00001_00010 |
| Stage | non_equity_assistance |
Website: www.orakl-oncology.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account